Human rhinovirus (HRV) is a major causative agent of the common cold, and thus has several important health implications. As a member of the picornavirus family, HRV has a small genomic RNA that utilizes several host cell proteins for RNA replication. Host proteins poly(rC) binding protein 2 (PCBP2) and polypyrimidine tract binding protein (PTB) are cleaved by a viral proteinase during the course of infection by the related picornavirus, poliovirus. The cleavage of PCBP2 and PTB inhibits poliovirus translation and has been proposed to mediate a switch in poliovirus template usage from translation to RNA replication. HRV RNA replication also requires a switch in template usage from translation to RNA replication; however, the mechanism is not yet known. We demonstrate that PCBP2 and PTB are differentially cleaved during HRV infection in different cell lines, suggesting that HRV utilizes a mechanism distinct from PCBP2 or PTB cleavage to mediate a switch in template usage.
Introduction
Human rhinovirus (HRV) is the most prevalent causative agent of the common cold, with 80% of common cold cases caused by HRV (Arruda et al., 1997) . Although the common cold is not known to cause a severe disease phenotype, it costs billions of dollars per year and contributes to lost wages (McErlean et al., 2008) . Additionally, HRV infections can be severe in individuals with chronic lung illnesses such as COPD, asthma, or allergies. HRV is a major cause of asthma exacerbations, causing up to 70% of asthma exacerbations in children and can increase the rate of morbidity from decreased lung function due to asthma (Johnston et al., 1996; Rakes et al., 1999) . Therefore, a better understanding of HRV will allow for antiviral drugs to be developed to help those with chronic lung illnesses. A potential impediment to development of an antiviral drug is that there are over 100 antigenically distinct serotypes of HRV. These serotypes can be divided into three groups, group A, group B, or group C. Additionally, serotypes are grouped based on the receptor used for host cell entry. Most HRV types use ICAM-I as a receptor and are known as the major group serotypes, while the remaining minor group types utilize a low-density lipoprotein (LDL) receptor.
HRV is a member of the Picornaviridae family of viruses, which also includes coxsackievirus, enterovirus 71, and poliovirus, the prototypic picornavirus, among others. Picornaviruses are a family of small, single-stranded, positive-sense RNA viruses that replicate in the cytoplasm of infected host cells. Unlike cellular mRNAs, picornavirus genomes lack a cap on the 5′ end and have a highly structured 5′ noncoding region (NCR) that precludes ribosome scanning (Fernandez-Munoz and Darnell, 1976; Fitzgerald and Semler, 2009; Hewlett et al., 1976; Nomoto et al., 1976) . Therefore, translation is initiated in a cap-independent manner. The 5′ NCR is composed of six stem-loop structures, where stem-loops II-VI make up the internal ribosome entry site (IRES) that mediates cap-independent, IRES-driven translation (Belsham and Sonenberg, 1996; Borman and Jackson, 1992; Jang et al., 1988; Pelletier and Sonenberg, 1988) . As a positive-sense RNA virus, the genome can serve as a template for both viral translation and RNA replication. Therefore, upon entry into the host cell, the viral genome is first used as a template for translation into a single polyprotein that is subsequently processed by viral proteinases, including 3CD, to produce viral proteins. Picornaviruses utilize host cell proteins, referred to as IRES trans-acting factors (ITAFs), to mediate non-canonical translation. Several host proteins have been shown to be important for poliovirus or HRV translation, including poly(rC) binding protein 2 (PCBP2), polypyrimidine tract binding protein (PTB), lupus autoantigen (La), and upstream of N-ras (unr) (Blyn et al., 1996 Gamarnik and Andino, 1997; Gosert et al., 2000; Hellen et al., 1993; Meerovitch et al., 1993; Sawicka et al., 2008; Svitkin et al., 1994) .
Following translation, the genomic RNA can be used as a template for synthesis of negative-strand RNA, followed by the subsequent synthesis of positive-strand RNA for further rounds of translation and RNA replication, or packaging into progeny virions. Previous studies have shown that although the viral genome can be used as a template for both translation and RNA replication, RNA that is actively being translated cannot function as a template for RNA replication (Barton Gamarnik and Andino, 1998) . This suggests that there must be a mechanism to mediate a switch in template usage from translation to RNA replication.
Multiple candidates have been proposed to play a role in the switch from viral translation to RNA synthesis, including PCBP2 and PTB. PCBP2 binds to stem-loop IV of the poliovirus IRES to form a complex that is required for translation of the polyprotein (Blyn et al., 1996 Gamarnik and Andino, 1997) . Additionally, PCBP2 binds to a stem-loop I structure upstream of the IRES and forms a ternary complex with viral proteinase 3CD that is required for initiation of negative-strand RNA synthesis (Andino et al., 1993 (Andino et al., , 1990 Andino, 1997, 1998; Parsley et al., 1997) . At peak times of viral RNA synthesis, PCBP2 is cleaved by poliovirus 3CD proteinase, disrupting the interaction of PCBP2 with stem-loop IV and inhibiting translation. However, the cleaved form of PCBP2 is still able to bind to stem-loop I and form a functional ternary complex, remaining active in RNA replication (Perera et al., 2007) . Additional studies have shown that PCBP2 is also cleaved during coxsackievirus infection and can be cleaved in vitro by HRV type 16 (HRV16) 3CD proteinase (Chase et al., submitted for publication). Therefore, these data suggest that cleavage of PCBP2 by viral 3CD proteinase could be important for mediating a switch in template usage for multiple picornaviruses.
PTB is an additional ITAF that stimulates poliovirus and HRV translation (Gosert et al., 2000; Hellen et al., 1993; Sawicka et al., 2008) . It has been shown that, like PCBP2, PTB is also cleaved during poliovirus or HRV type 14 (HRV14) infection, and the cleavage is mediated by the viral proteinase 3C (Back et al., 2002) . PTB is a member of the hnRNP family and shuttles from the nucleus to the cytoplasm (Michael et al., 1995) . Cleavage of PTB results in the redistribution of the cleaved fragments to the cytoplasm and the inhibition of poliovirus translation. While the mechanism of how PTB cleavage inhibits translation is not known, it has been proposed that the cleaved fragments bind viral RNA to preclude binding of fulllength, functional PTB (Back et al., 2002) . Thus, it has been proposed that cleavage of cellular protein PTB by viral proteinase 3C could also play a role in mediating a switch in template usage.
Cleavage of PCBP2 is required for efficient poliovirus RNA replication, and plays an important role in mediating a switch in template usage from translation to RNA replication (Chase et al., submitted for publication). Since PCBP2 is cleaved by HRV16 viral proteinase 3CD, this suggests that cleavage of PCBP2 could also be important for HRV RNA replication and the switch in template usage. However, the role host cell proteins play in HRV infection and the importance of PCBP2 or PTB cleavage during HRV infection is not yet understood. To more fully explore these mechanisms, PCBP2 cleavage was investigated during infection with three different HRV serotypes, types 14, 16, and 1A, which includes serotypes from groups A or B and serotypes that use either the major or minor group receptor. HRV14 and HRV16 utilize the major ICAM-1 receptor, while HRV1A uses the minor group LDL receptor. In addition, HRV14 is grouped into group B, while HRV16 and HRV1A are group A serotypes. We found that PCBP2 and PTB are cleaved during infection of HeLa cells by all three HRV serotypes investigated; however, neither protein was cleaved during infection of a human lung fibroblast cell line, suggesting differential cleavage of host cell proteins. In addition, unlike poliovirus, cleavage of PTB or PCBP2 does not appear to be required for efficient human rhinovirus infection.
Results

Cleavage of purified recombinant PCBP2 in vitro by poliovirus or HRV 3CD proteinases
Previous studies have shown that PCPB2 is cleaved by poliovirus proteinase 3C or precursor 3CD (Perera et al., 2007) . To determine if PCBP2 is also cleaved by HRV 3CD proteinase, recombinant poliovirus or HRV16 3CD proteinase was incubated with purified PCBP2, and the electrophoretic mobilities of PCBP2 and cleavage products were analyzed by Western blot (Fig. 1 ). PCBP2 and HRV16 or poliovirus 3CD proteinase recombinant proteins were incubated for varying amounts of time, as indicated. The level of cleaved PCBP2 increases during the first 2 h and then remains consistent during the remainder of the incubation period. Comparing PCBP2 cleavage by poliovirus 3CD (lanes 2-5) to cleavage by HRV16 3CD (lanes 6-9), the levels of cleaved PCBP2 are similar. We have also shown that HRV14 3CD can cleave PCBP2 with a similar efficiency (data not shown). These data suggest that HRV 3CD can cleave PCBP2 as efficiently as poliovirus 3CD, further suggesting that PCBP2 cleavage could be important during HRV infection.
Cleavage of PCBP2 during HRV infection
Although HRV 3CD can cleave PCBP2 in vitro, the question remains as to whether PCBP2 cleavage occurs during the course of HRV infection. To address this question, HeLa cells were infected with different serotypes of HRV, and cleavage of PCBP2 was analyzed by Western blot, using antibodies specific for PCBP2. HRV has slower growth kinetics than poliovirus, with peak titers reached at 10 h post-infection compared to 4 h for poliovirus (data not shown) (Lee and Wang, 2003) . Therefore, extracts were harvested out to 16 h post-infection to account for the protracted time course. As expected, no cleavage of PCBP2 was detected in mock-infected HeLa cells ( Fig. 2A) . In HRV14-infected HeLa cells, PCBP2 cleavage was not detected until 14 h post-infection (Fig. 2B) . Additionally, cleaved PCBP2 could only be observed when four times the total protein concentration was analyzed compared to poliovirus. Human rhinovirus grows optimally in tissue culture at 34 1C, whereas poliovirus grows and replicates optimally at 37 1C, although our work and the work of others has recently shown that HRV16 and HRV14 can also replicate efficiently at 37 1C (data not shown) (Papadopoulos et al., 1999) . To determine if the lower growth temperature contributes to the cleavage of PCBP2 seen during HRV14 infection, poliovirus infection was carried out in HeLa cells at 34 1C as a comparison. When HeLa cell lysates from poliovirus-infected cells were analyzed by Western blot, PCBP2 cleavage was detected at 6 h post-infection (Fig. 2C ). While this is slightly delayed relative to cleavage of PCBP2 during poliovirus infection at 37 1C, which is detected at 4 h post-infection, it still occurs much earlier than what was observed during HRV14 infection (Chase et al., submitted for publication; Perera et al., 2007) . These results suggest that cleavage of PCBP2 during HRV14 infection is less efficient than during poliovirus infection. To determine if other rhinovirus serotypes cleave PCBP2 more Fig. 1 . Cleavage of recombinant PCBP2 by 3CD proteinase. Recombinant PCBP2 was incubated with purified poliovirus or HRV16 3CD for 1 to 6 h, as indicated. PCBP2 alone is in lane 1. PCBP2 was incubated with recombinant poliovirus 3CD (lanes 2-5) or recombinant HRV16 3CD (lanes 6-9). The arrows to the right of the gel image indicate full-length or cleaved PCBP2. Molecular weight markers are indicated to the left of the gel image.
efficiently than HRV14, HeLa cells were infected with a group A HRV serotype, type 16 (HRV16), which is more similar in sequence to circulating HRV serotypes than HRV14. Again, in mock-infected cells, only full-length PCBP2 is detected (Fig. 3A) . PCBP2 cleavage during HRV16 infection was observed by 10-12 h post-infection, delayed relative to cleavage during poliovirus infection, but not as delayed as cleavage during HRV14 infection (Fig. 3B ). Although cleavage of PCBP2 is delayed until 10 h post-infection during HRV16 infection, it corresponds to the delayed growth kinetics compared to the poliovirus growth kinetics. These data confirm that PCBP2 can be cleaved during human rhinovirus infection of HeLa cells.
PCBP2 remains intact during HRV infection of lung fibroblast cells
To further determine the importance of PCBP2 cleavage during rhinovirus infection, a human lung fibroblast-derived WisL cell line was utilized (Bochkov et al., 2011) . As HRV infects the respiratory tract, this cell line may allow for analysis of HRV infection of cells more relevant than the standard HeLa cell model. Cytoplasmic extracts from WisL cells infected with HRV16 were collected and analyzed at indicated times post-infection. As seen in Fig. 3C , cleavage products of PCBP2 cannot be detected out to 42 h (lane 10), and this was consistent when four times the total protein concentration was analyzed (data not shown).
To ensure that a productive infection was occurring, cytoplasmic lysates from HRV16-infected HeLa cells or WisL cells were analyzed by Western blot, using an antibody specific for HRV16 3D RNA-dependent RNA polymerase. Viral proteins 3D and 3CD precursor were detected at 8 h post-infection of WisL cells (Fig. 4A ). During HRV16 infection of HeLa cells, viral proteins were detected at 6 h post-infection (Fig. 4B ). The production of viral proteins suggesting productive HRV infection of WisL cells was further supported by single cycle growth analysis showing similar growth during HRV16 infection of WisL cells compared to growth kinetics during HRV16 infection of HeLa cells (Fig. 4C ). Both the growth analysis and production of viral proteins indicate that HRV16 can productively infect WisL lung fibroblast cells, although PCBP2 is not cleaved. Therefore, we conclude that HRV16 can productively infect WisL cells in the absence of PCBP2 cleavage.
To determine if PCBP2 can be cleaved in WisL cells, a poliovirus infection of WisL cells was carried out. Following infection, cytoplasmic lysate was harvested at indicated times post-infection, and PCBP2 cleavage was analyzed by Western blot. In contrast to HRV16 infection, cleavage of PCBP2 during poliovirus infection of WisL cells is readily detected at 6 h post-infection, indicating that PCBP2 can be cleaved during infection of WisL cells (Fig. 5A ). While the cleavage of PCBP2 during poliovirus infection of WisL cells was slightly delayed relative to HeLa cells (detected at 4 h post-infection), it corresponds to a slight delay in growth kinetics, as indicated by the slightly delayed detection of viral proteins (Fig. 5B ). During infection of WisL cells, poliovirus 3CD proteinase and 3D polymerase are detected at 4 and 6 h post-infection, respectively, which is slightly delayed relative to detection during infection of HeLa cells, when viral proteins are detected by 3 h post-infection. These data demonstrate that poliovirus productively infects WisL cells, and that PCBP2 can be cleaved in WisL cells during poliovirus infection. Therefore, the lack of cleavage observed during HRV16 infection appears to be unique to HRV infection.
To further characterize the cleavage state of PCBP2 during HRV infection, WisL cells were infected with a group B serotype (HRV14), which also utilizes the major group receptor, similar to group A serotype HRV16, or with minor group HRV1A (Fig. 6) . During HRV14 infection of HeLa cells, cleaved PCBP2 is barely detected at 12 h post-infection, but is readily detected by 24 h post-infection (lanes 5 and 6). Similar to HRV16 infection, PCBP2 is not cleaved during HRV14 infection of WisL cells (Fig. 6A, lanes  3 and 4) . These data demonstrate that major group HRV serotypes 14 and 16 are able to cleave PCBP2 in HeLa cells, but this cleavage event does not appear to be required for efficient infection of WisL cells. To determine if the observed lack of cleavage in WisL cells was unique to major group rhinovirus types, WisL cells were infected with minor group HRV1A. Similar to HRV14 and HRV16, at 24 h post HRV1A infection of HeLa cells, cleaved PCBP2 is readily detected (Fig. 6B, lane 7) . Additional studies have shown that PCBP2 cleavage during HRV1A infection of HeLa cells can also be detected at 16 h post-infection, similar to both HRV14 and HRV16 (data not shown). However, during HRV1A infection of WisL cells, cleaved PCBP2 is not detected (Fig. 6B, lanes 4 and 5) , consistent with what we observed for HRV16 or HRV14 infection of WisL cells. Collectively, these data suggest that PCBP2 cleavage is not necessary for efficient HRV infection of WisL cells.
Cleavage of polypyrimidine tract binding protein during HRV infection
Previous studies have shown that cellular protein polypyrimidine tract binding protein (PTB) enhances both poliovirus and HRV IRES-mediated translation (Gosert et al., 2000; Hellen et al., 1993; Sawicka et al., 2008) . Additionally, PTB can be cleaved during poliovirus infection by 3C/3CD proteinase, and it has been proposed that the cleavage event can help mediate a switch in template usage from translation to RNA replication (Back et al., 2002) . It has been reported that all three PTB isoforms (PTB-1, -2, and -4) can be cleaved by 3CD, producing two major cleavage products at 41 kDa and 39 kDa, and a minor cleavage product at 16 kDa (Back et al., 2002) . Therefore, this protein may also be cleaved during HRV infection to help mediate initiation of RNA replication by inhibiting translation to allow a switch in template usage. To determine the cleavage state of PTB during HRV infection, lysates from HRV16-infected HeLa cells were analyzed by Western blot with an antibody specific for PTB. During infection of HeLa cells at 34 1C, cleavage was detected by 12 h post-infection (Fig. 7A, lane 7) , and cleavage can also be detected as early as 10 h post-infection (data not shown). Additionally, PTB cleavage was detected by 12 h post-infection during HRV14 infection of HeLa cells (Fig. 7A, lane 11) . During HRV16 or HR14 infection, three cleavage products were detected, two products with molecular masses of approximately 27-30 kDa, and a product with a molecular mass of approximately 13-14 kDa. To further determine if PTB cleavage occurs during HRV infection, WisL lung fibroblast cells were infected with HRV16 or HRV14 and lysates were collected at the indicated times post-infection and analyzed by Western blot. Similar to what we observed for PCBP2, only trace levels of PTB cleavage were detected in HRV16-infected WisL cells (Fig. 7A, lanes 3 and 4) . To confirm the lack of cleavage, 2.5 times the total protein concentration in lysates from WisL cells infected with HRV16 was analyzed, and again only trace levels of PTB cleavage were detected (Fig. 7A , lanes 5 and 6, indicated by the asterisk). However, during HRV14 infection, PTB cleavage products were detected by 12 h post-infection; however, only low levels of the largest PTB cleavage product PTB could be detected at 24 h postinfection (Fig. 7A, compare lanes 9 and 10) . This suggests that PTB cleavage is not required for efficient HRV16 infection, but PTB cleavage may play a role in HRV14 infection. However, the cleavage of PTB appears to be inefficient in HRV14-infected cells, perhaps limiting the possible role of this event in the HRV14 replication cycle.
To further analyze cleavage of PTB during HRV infection, cytoplasmic lysates from HeLa or WisL cells infected with minor receptor group serotype HRV1A were analyzed, as shown in Fig. 7B . During infection of HeLa cells, cleaved PTB was detected by 12 h postinfection (lane 2), and at 24 h post-infection both higher and lower molecular weight PTB cleavage products were detected (lane 3). However, during infection of WisL cells by HRV1A, only a trace amount of PTB cleavage product is detected at 12 or 24 h postinfection (lanes 5 and 6). From these data, it can be concluded that while PTB cleavage occurs during HRV infection of HeLa cells, it is not detected during HRV infection of WisL cells and does not appear to be necessary for HRV replication in these cells. 
Differential cleavage of host proteins during coxsackievirus infection of different cell types
Coxsackievirus, also a member of the picornavirus family of viruses, has similar growth properties to poliovirus. Coxsackievirus grows and replicates optimally at 37 1C and has similar replication kinetics, with peak titer being reached at 5 h post-infection. PCBP2 is cleaved during coxsackievirus infection at a similar time postinfection to PCBP2 cleavage during poliovirus infection (Chase et al., submitted for publication). To determine if coxsackievirus cleaves PCBP2 differentially in HeLa versus WisL cells, both cell lines were infected with coxsackievirus and the resulting cytoplasmic lysates from infected cells were analyzed by Western blot. During coxsackievirus infection of HeLa cells, PCBP2 is cleaved beginning at 4-6 h post-infection (Fig. 8A) , further demonstrating that PCBP2 cleavage during coxsackievirus infection is similar relative to cleavage during poliovirus infection. However, during coxsackievirus infection of WisL human lung fibroblast cells, only a small amount of cleaved PCBP2 is detected at 12 h post-infection (Fig. 8B) . This is delayed relative to observed PCBP2 cleavage at 6 h following poliovirus infection of WisL cells, indicating that coxsackievirus may cleave PCBP2 differentially based on cell type.
To further characterize differential cleavage of host proteins during coxsackievirus infection, PTB cleavage was analyzed in WisL or HeLa cells infected with coxsackievirus. Cytoplasmic lysates from HeLa-or WisL-infected cells were analyzed by Western blot for PTB cleavage. As shown in Fig. 8C , the higher molecular weight PTB cleavage products are detected at 4 h postinfection in HeLa cells, and the lower molecular weight product is seen by 8 h post-infection. During coxsackievirus infection of WisL cells, only one of the major PTB cleavage products is detected at 6 h post-infection, and is more readily detected at 8 h postinfection (Fig. 8D ). Similar to PCBP2 cleavage, a very low level of cleaved product is observed relative to infection of HeLa cells, further suggesting that there is a significant difference in cleavage of host cell proteins PTB and PCBP2 during coxsackievirus infection, based on cell type being infected. Taken together, these data suggest that, unlike poliovirus infection, cleavage of host cell proteins PCBP2 or PTB is not required for efficient HRV or coxsackievirus infection.
Discussion
Human rhinovirus translation is driven in a cap-independent, IRES-dependent manner. Several host cell proteins help mediate this non-canonical translation, known as IRES trans-acting factors (ITAFs), including PCBP2 and PTB (Blyn et al., 1996 Gamarnik and Andino, 1997; Gosert et al., 2000; Hellen et al., 1993; Sawicka et al., 2008) . PCBP2 is cleaved during poliovirus infection by the 3CD proteinase, and it has been proposed that the cleavage event helps mediate a switch in template usage by inhibiting translation (Perera et al., 2007) . Additionally, PTB is known to stimulate both poliovirus and HRV translation. Cleavage of PTB by poliovirus 3C proteinase also leads to an inhibition in translation, and thus has also been proposed to be involved in mediating a switch in template usage (Back et al., 2002; . The picornavirus genome can be used as a template for both translation and RNA replication, and it has been shown that a template actively being translated cannot function as a template for RNA replication (Barton et al., 1999; Gamarnik and Andino, 1998) . A switch in template usage is essential for efficient viral RNA synthesis, and could therefore be important for the progression of the replication cycle.
HRV serotypes can be divided into group A, group B, or group C, and also by the receptor used to mediate cell entry; major group serotypes use ICAM-I and minor group serotypes utilize lowdensity lipoprotein (LDL) receptor. To provide a more comprehensive study of the cleavage or use of host cell proteins PCBP2 and PTB during human rhinovirus infection, serotypes representing different groups were studied. HRV16, group A, and HRV14, group B, are both major group serotypes, and HRV1A, group A, is a minor group serotype. PCBP2 and PTB were both shown to be cleaved during the course of HRV14, HRV16, or HRV1A infection of HeLa cells, suggesting that PCBP2 might also be important for a switch in template usage during HRV infection of HeLa cells. During HRV16 or HRV14 infection of HeLa cells, PCBP2 cleavage is detected at 10 or 14 h post-infection, respectively, while cleavage is also detected prior to 24 h during HRV1A infection (Figs. 2, 3 , and 6; summarized in Table 1 ). In contrast, HRV infected WisL human lung fibroblast cells showed a lack of PCBP2 cleavage out to 24 h post-infection during HRV16, HRV14, or HRV1A infection ( Figs. 3 and 6 ; Table 1 ). However, single cycle growth analysis and Western blot analysis with an antibody specific for HRV16 3D polymerase indicated that there was a productive HRV16 infection occurring in WisL cells (Fig. 4) . Additionally, although slightly delayed, PCBP2 cleavage was observed in WisL cells during poliovirus infection. The observed delay is consistent with the delay in viral protein accumulation, suggesting that poliovirus infection may be slightly delayed in WisL cells, but that cleavage of PCBP2 is still necessary for infection (Fig. 5) . This demonstrates that PCBP2 can be cleaved in WisL cells, and that the lack of observed cleavage in this cell line appears to be unique to HRV infection.
As it is known that other cellular proteins such as PTB can be cleaved by 3C proteinase, and the cleavage could also help mediate a switch in template usage, further analysis was carried out on cleavage of PTB during HRV infection of WisL cells. The data showed that PTB was cleaved during HRV14, HRV16, or HRV1A infection of HeLa cells, but similar to PCBP2, PTB was also not cleaved efficiently during HRV infection of WisL cells (Fig. 7 , Table 1 ). Because HRV can establish a productive infection of WisL cells, our data suggest that cleavage of PCBP2 or PTB is not necessary for efficient HRV infection of these cells.
Coxsackievirus has similar growth kinetics to poliovirus, and it has been shown that PCBP2 is cleaved during coxsackievirus infection of HeLa cells with similar kinetics to cleavage during poliovirus infection (Chase et al., submitted for publication). Therefore, we hypothesized that PCBP2 cleavage would also occur during coxsackievirus infection of WisL cells, similar to what was observed during poliovirus infection of WisL cells (Fig. 5) . However, PCBP2 cleavage was significantly delayed and less efficient during coxsackievirus infection of WisL cells compared to infection of HeLa cells. When cleavage of PTB was analyzed, there was a similar occurrence in which PTB cleavage was both less efficient and delayed. Taken together, these data suggest that efficient coxsackievirus infection of WisL cells does not require PCBP2 or PTB cleavage.
Our results lead to several questions, including why PCBP2 and PTB are cleaved during infection of HeLa cells but not in WisL cells, and if there are other, as yet undefined, ITAFs that are important for HRV and/or coxsackievirus translation in WisL cells that may be less abundant in HeLa cells. Additional studies are necessary to better understand the intracellular determinants required for HRV translation and RNA replication, and work will need to be done in multiple cell lines including, but not limited to, HeLa cells and WisL cells. Since PCBP2 and PTB are cleaved during poliovirus infection of WisL cells, the reason PCBP2 and PTB are differentially cleaved during HRV infection of WisL cells but not during poliovirus infection is not understood. Perhaps there is a lower concentration of PCBP2 present in replication complexes formed during infection of WisL cells, leading to the decreased detection of cleaved PCBP2. During HRV infection of HeLa cells, PCBP2 cleavage is delayed relative to cleavage during poliovirus infection, suggesting that PCBP2 cleavage may be less efficient during HRV infection, and the lower local concentration of PCBP2 would result in a lack of detectable levels of PCBP2 cleavage. Alternatively, PCBP2 or PTB may be bound to cellular RNA or host cell proteins, making them unavailable as cleavage substrates during HRV infection of WisL cells.
It has been proposed that cleavage of both PCBP2 and PTB helps to mediate a switch in poliovirus template usage from translation to RNA replication to allow the progression of RNA synthesis (Back et al., 2002; Perera et al., 2007) . Therefore, the question remains as to what mediates the switch in HRV template usage. The cellular protein upstream of N-ras (unr) has been shown to be important for HRV translation, and can stimulate HRV translation alone and synergistically with PTB . Thus, unr could be an important protein involved in template switching . However, preliminary data suggests that unr is not cleaved in either HeLa cells or WisL cells during HRV16 infection (data not shown).
Previous studies have shown that when 3CD is bound to stemloop I, levels of translation are decreased while levels of RNA replication increase, and, correspondingly, in the absence of bound 3CD, translation is increased (Gamarnik and Andino, 1998) . Subsequent work indicated that in the presence of 3CD, PCBP2 preferentially binds to stem-loop I. The apparent dissociation constant of PCBP2 for poliovirus stem-loop IV is approximately 15 nM, while that of PCBP2 to stem-loop I, in the absence of 3CD, is approximately 95 nM. In the presence of 3CD, the dissociation constant of PCBP2 for stem-loop IV is unaltered, but that of PCBP2 for stem-loop I changes to approximately 1 nM (Gamarnik and Andino, 2000) . Additionally, competition assays indicated that PCBP2 bound to poliovirus stem-loop IV can be reduced in the presence of 3CD bound to stem-loop I (Gamarnik and Andino, 2000) . As originally proposed by Gamarnik and Andino (1998) for poliovirus, the shift in the binding affinity of PCBP2 for stem-loop I over stem-loop IV in the presence of 3CD could help mediate a switch in template usage from translation to RNA replication independent of the cleavage state of PCBP2 or PTB. As translation of the genomic template proceeds, the concentration of viral proteins, including 3CD, would increase. 3CD interacts with stem-loop I, shifting the occupancy of PCBP2 from stem-loop IV to stem-loop I, and in the process inhibits translation while allowing the initiation of negative-strand RNA synthesis. The change in PCBP2 binding affinity from stem-loop I to stem-loop IV in the presence of 3CD proteinase could be the fundamental mechanism mediating template switching, and could be augmented by cleavage of host cell proteins such as PCBP2 and PTB by viral proteinase 3CD. Since it has been shown that PCBP2 cleavage is important for poliovirus infection, the cleavage of PCBP2 would mediate a more efficient or a faster switch in template usage. As coxsackievirus infection has similar growth properties as poliovirus infection, this would suggest that an alternative mechanism, that is as yet unknown, helps improve the switch in template usage. HRV growth and replication are delayed relative to poliovirus, which could be attributed to a less efficient switch in template usage, leading to a delay in RNA synthesis. During poliovirus infection, the template switch could occur more quickly as cellular protein PCBP2 is cleaved by 3CD to inhibit the RNP complex formed between PCBP2 and stem-loop IV, potentiating the change in PCBP2 binding from stem-loop IV to stem-loop I. Further studies are necessary to identify the mechanism(s) that mediate a switch in HRV template usage.
Materials and methods
HRV16 3CD construct
Synthetic oligonucleotide primers used were: HRV16-3CD-Nde (þ) (5′ agccatatgggtccagaagaagaattt 3′), HRV16-3CD-BamHI( À ) (5′ gccggatccctattaagaatttttcatacatt 3′), HRV16-3CDμ10( þ) (5′ atcatacttcactgaacaagcagcccaaattcaaatctctaaac 3′), HRV16-3CDμ10( À ) (5′ gtttagagatttgaatttgggctgcttgttcagtgaagtatgat 3′). Synthetic oligonucleotide primers HRV16-3CD-Nde (þ ) Back et al. (2002) .
and HRV16-3CD-BamHI( À ) were used to generate PCR fragments containing HRV16 amino acids 5155 to 7085, flanked by NdeI or BamHI upstream or downstream, respectively. The restriction sites were then used to clone HRV16 3CD into the pET15b vector through ligation. Site-directed mutagenesis of the newly synthesized pET15b HRV16 3CD plasmid was then used as a template for site-directed mutagenesis to alter the 3C/D self-cleavage site such that recombinant 3CD could not be self-cleaved into 3C and 3D. The synthetic oligonucleotide primers used were HRV16-3CDμ10 (þ ) and the reverse complement, HRV16-3CDμ10( À ). The resulting plasmid, pET15b HRV16 3CDμ10, was used for protein expression.
Protein purification
Purification of hexahistidine-tagged pET22b PCBP2 was carried out as previously described (Parsley et al., 1997; Perera et al., 2007) . Briefly, PCBP2 was expressed in BL21DE3 (Rosetta) cells. The cells were grown at 37 1C to an A 600 of 0.6 and then induced with isopropyl-β-Dthiogalactopyranoside (IPTG; 1 mM concentration) for 3 h at 25 1C. Hexahistidine-tagged 3CD viral proteinase (poliovirus or HRV16) was purified as previously described, with minor modifications (Parsley et al., 1999 (Parsley et al., , 1997 . Briefly, 3CD was expressed in BL21DE3 (Rosetta) cells, and the cells were grown at 37 1C to an A 600 of 0.4. The protein expression was induced by the addition of IPTG (1 mM) for 3 h at 25 1C. Cells were resuspended in Buffer A (20 mM Tris-HCl [pH 8.0], 25 mM NaCl, 5% glycerol, 1 mM DTT, added fresh) and lysed by one passage through a French pressure cell (Amicon) at 8,000 psi. The lysate was then subjected to centrifugation for 20 min at 13,800g using a Beckman Coulter centrifuge and JA-17 rotor and the resulting supernatant was discarded. The pellet was washed three times in Buffer A, the last wash without DTT. To extract protein from the pellet fraction, the pellet was resuspended in high salt I-30 buffer (20 mM Tris-HCl [pH 8.0], 1 M NaCl, 30 mM imidazole, 10% glycerol) and incubated on ice for 30 min. The resuspended pellet was then subjected to centrifugation for 20 min at 13,800g as above. The resulting supernatant was subjected to Ni 2 þ ion-based affinity chromatography (GE Healthcare). The column was washed with high salt I-30 buffer, and the protein was eluted with high salt I-200 buffer (20 mM Tris-HCl [pH 8.0], 1 M NaCl, 200 mM imidazole, 10% glycerol).
In vitro cleavage assay
The in vitro cleavage assay was carried out as previously described, with some minor changes (Perera et al., 2007) . Briefly, recombinant purified PCBP2 and poliovirus or HRV16 3CD proteinase were incubated at a 1:1 M ratio in cleavage buffer (20 mM HEPES [pH 7.4], 1 mM DTT, 150 mM KOAc) for 1 to 6 h at 30 1C. The cleavage products were analyzed by SDS-PAGE and Western blot.
Western blot analysis
Following SDS-PAGE, proteins were electroblotted to a PVDF membrane. The membranes were blocked in 5% milk in phosphate buffered saline (PBS) with 0.1% Tween-20 for 1 h at room temperature. Mouse monoclonal antibody against PCBP2 (1:2000 in PBS with 0.1% Tween-20), as described in Sean et al., was used to detect full-length and cleaved forms of PCBP2 (Sean et al., 2008) . To detect PTB protein, mouse monoclonal antibody against PTB (1:2000 in PBS with 0.1% Tween-20) was used. Poliovirus viral proteins were analyzed with a rabbit polyclonal antibody against poliovirus 3CD proteinase (Cathcart et al., 2013) . HRV16 viral proteins were detected with a rabbit polyclonal antibody against HRV16 3D RNA-dependent RNA polymerase. A synthetic HRV16 3D peptide was generated and used to induce antibody production in rabbits (Bethyl). The PVDF membrane was incubated with anti-PCBP2, anti-PTB, anti-poliovirus 3CD, or anti-HRV16 3D antibody (1:2000) for 1 h. This was followed by incubation with goat anti-mouse horseradish peroxidase (HRP) secondary antibody (Millipore) or goat anti-rabbit HRP antibody (Millipore) for 1 h. Protein bands were visualized using chemiluminescence (Thermo Scientific).
Virus infection and cell culture
HeLa cells were grown as monolayers in Dulbecco's modified Eagle's medium (DMEM) supplemented with 8% newborn calf serum (NCS). WisL human fetal lung fibroblast cells (Bochkov et al., 2011) were grown as monolayers in DMEM supplemented with 10% fetal bovine serum (FBS). Cells (HeLa or WisL) were infected with poliovirus, coxsackievirus B3 (CVB3), HRV14, HRV16, or HRV1A at a multiplicity of infection (MOI) of 20, and adsorption was carried out at room temperature for 60 min for HRV or 30 min for poliovirus and coxsackievirus. HRV1A virus stock was kindly provided by Dr. Yury Bochkov (University of Wisconsin-Madison). DMEM with 8% NCS (HeLa cells) or 10% FBS (WisL cells) was added, and the cells were incubated at 34 1C or 37 1C, as specified, until the indicated times. At specific times post-infection, cells were washed twice with phosphate buffered saline (PBS), scraped, and collected to generate cytoplasmic lysates. Cells were lysed in NP-40 lysis buffer (50 mM Tris-HCl [pH 8.0], 5 nM EDTA [pH 8.0], 150 mM NaCl, 0.5% NP-40) on ice for 30 min. After incubation on ice, cells debris was pelleted, the resulting supernatant was collected, and total protein concentration was determined by Bradford assay. Total protein (100 μg) from cytoplasmic lysates were analyzed by Western blot. Where indicated, four times total protein concentration (400 ug) or 2.5 times total protein concentration (250 ug) was analyzed.
For single cycle growth analysis, HeLa cells or WisL cells were infected with HRV16 at an MOI of 20 as above. Cells were washed three times with phosphate buffered saline (PBS) following the adsorption prior to adding media. At designated times postinfection (0-12 h), supernatant and cells were collected and subjected to four rounds of freeze-thawing. To determine the titer of virus at each time point, the collected virus was then diluted in serum-free media and the dilutions were used to infect HeLa cell monolayers (as above). Following adsorption, the cells were overlaid with DMEM plus 8% NCS and 0.45% agarose. Seven days after infection, the cells were treated with 10% trichloroacetic acid (TCA) and stained with crystal violet (0.1% crystal violet, 25% ethanol). The plaques were counted to determine the virus titer.
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